$9.2 billion market by 2027, up from $3.3 billion in 2022

Global CRISPR Technology Market

Dublin, Jan. 25, 2023 (GLOBE NEWSWIRE) — The CRISPR Technology: Global Markets report has been added to ResearchAndMarkets.com supply.

This report provides detailed information on the CRISPR Technology market. This report highlights the current and future market potential of CRISPR technology along with a detailed analysis of market drivers, restraints, and challenges.

The report also covers the market forecasts to 2027 as well as the competitive landscape and regulatory scenario. The report details the CRISPR technology market share on applications and end users. The market is segmented into biotech and pharmaceutical companies, academia and government research institutes, and contract research organizations (CROs) on the basis of end users.

The market is categorized as drug development, agriculture, diagnostics, clinical therapy, and others on the basis of application. The report includes company profiles of key players with detailed information on their business segments, financials, product portfolios and recent developments. The report also discusses the impact of the COVID-19 pandemic on this market.

By geography, the market is segmented into North America, Europe, Asia Pacific and Rest of the World. The North America region includes countries such as the US and Canada; Europe includes Germany, the United Kingdom, France and the rest of Europe; The Asia-Pacific region includes China, India, Japan and the rest of the Asia-Pacific region. For market estimates, data is provided for 2019 as a historical year, 2021 as a base year, and a forecast for 2027.

Key indicators

Reasons for conducting this survey:

• CRISPR offers lucrative potential for advanced pharmacological research, with impact spanning the entire preclinical drug discovery process. This technology makes gene editing more tractable and precise and speeds up the process of identifying drug targets and generating realistic disease models. The high costs associated with new drug innovation are a risk for pharmaceutical companies and can limit the discovery of new therapeutics. New and advanced technologies such as CRISPR are removing these barriers, expanding the drug discovery process.

• This report examines end users, applications and markets in an effort to help companies and investors prioritize product opportunities and strategic moves. The report highlights key industry and market trends and quantifies key market segments, allowing the reader to better understand the structure of the industry and the changes occurring within it.

• Favorable government regulations and funding that support the application of CRISPR in various scientific fields in all regions create unique market opportunities. This report analyzes the trends and impact on the future growth and development opportunities of CRISPR applications in science.

The story continues

The report includes

• 17 data tables and 37 supplementary tables

• Current overview and analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology

• Global market trend analyses, with historical revenue data 2019-2021, forecasts to 2022, and CAGR forecasts to 2027.

• Highlights of CRISPR Technology market potential, industry growth drivers and areas of focus to forecast this market across various segments and sub-segments

• Estimation of the actual market size and revenue forecast for the global CRISPR technology market in USD million and corresponding market share analysis by application, end user and region

• Discussion of key market dynamics, key changes and regulations, industry-specific challenges and macroeconomic factors influencing the demand for CRISPR technology market in the coming years (2022-2027)

• Identifying the companies best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages

• A look at the recent technical breakthrough in the use of CRISPR-Cas9 genome editing technology and how it has driven rapid growth in genetic engineering and advanced pharmacology research

• A comparative study of CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion of its higher adaptability over other nucleases

• Review of patent applications and scientific publications for innovations in the CRISPR-Cas9 genome editing technology

• Insights into the recent CRISPR-Cas9 Genome Editing Technology industry structure, competitive landscape, clinical trials, ongoing research activities, and the impact of COVID-19 on the market

Company profiles of major industry players including

Main topics covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market overview
3.1 Crispr: Genetic Editing
3.2 Components of Crispr-Cas Systems
3.2.1 Sgrna
3.2.2 Cas9 nucleases
3.3 How does Crispr-Cas work?
3.4 Advantage of the Crispr-Cas9 System
3.5 Popularity of Crispr genome editing
3.6 Advantages of genetic editing
3.7 Crispr Development Phases
3.7.1 Discovery of Crispr
3.7.2 Detection of Cas9 and Pam
3.7.3 Hypothesis: Adaptive immunity
3.7.4 Adaptive immunity
3.7.5 Separation sequences: Grnas
3.7.6 Crispr acts on DNA targets
3.7.7 Cas9 cleaves the target DNA
3.7.8 Tracrrna for Cas9 systems
3.7.9 Crispr systems in other species
3.7.10 Cas9-mediated cleavage
3.7.11 Crispr-Cas9: Genome Editing
3.8 Market Potential
3.9 Regulatory Framework
3.9.1 US Regulation and Supervision
3.9.2 Nih Guidelines
3.9.3 US Fda
3.9.4 Regulatory Matters
3.9.5 Rules for Human Germline Edits
3.9.6 Global Provisions
3.10 Porter’s Five Forces Analysis of the Market for Crispr Technology
3.11 Scientific Publications
3.12 Patent Analysis
3.12.1 Overview of the Intellectual Property (Ip) and Licensing Structure of the Crispr Technology
3.13 Future of Crispr
3.14 Market Engines
3.14.1 Crispr against chronic disease
3.14.2 High prevalence of genetic diseases
3.14.3 Government and Private Funding
3.14.4 Augmenting Crispr Applications
3.15 Market Restrictions
3.15.1 Alternative Technologies
3.15.2 Non-target activity
3.16 Market Challenges
3.16.1 Patent Matters
3.16.2 Risks Related to Crispr
3.16.3 R&D
3.16.4 Government Policies and Regulations
3.16.5 Bioethical Issues

Chapter 4 Industry Structure
4.1 Commercial therapeutic agents
4.2 Correction of Genetic Errors
4.3 Microbes
4.4 Healthier food

Chapter 5 Impact of Covid-19 on the Crispr Technology Market
5.1 Overview

Chapter 6 Competitive landscape
6.1 Overview
6.2 Competition Scenario
6.3 Radiation therapy
6.4 Crispr Therapeutics
6.5 Published Medicine
6.6 Intellia Therapeutics
6.7 Growth Strategies
6.7.1 Licensing and Agreements
6.7.2 Collaboration with major biopharmaceutical companies
6.7.3 Mergers and Acquisitions

Chapter 7 Global Market for Crispr Technology by End User
7.1 Market Overview
7.2 Market share and forecast
7.3 Biotechnology and pharmaceutical companies
7.4 Academic and Government Research Institutes
7.5 Contract Research Organizations

Chapter 8 Global Market for Crispr Technology by Application
8.1 Market share and forecast
8.2 Drug Development
8.3 Agriculture
8.4 Diagnostics
8.4.1 Infectious diseases
8.4.2 Non-infectious diseases
8.5 Clinical Therapy
8.6 Others

Chapter 9 Global Market for Crispr Technology by Region
9.1 North America
9.1.1 United States
9.1.2 Canada
9.2 Europe
9.2.1 Germany
9.2.2 United Kingdom
9.2.3 France
9.2.4 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Rest of the Asia-Pacific region
9.4 Rest of World

Chapter 10 Company Profiles

For more information on this report, visit https://www.researchandmarkets.com/r/21d81y

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We bring you the latest data on international and regional markets, key industries, leading companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900